Related Experiment Video
Updated: May 18, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Successful treatment of reactive hypoglycemia secondary to late dumping syndrome using miglitol
Yukari Fujita1, Daisuke Tamada, Junji Kozawa
1Department of Metabolic Medicine, Graduate School of Medicine, Osaka University, Japan.
Abstract:
We herein describe a 59-year-old woman who had undergone a total gastrectomy for gastric carcinoma and suffered from postprandial hypoglycemia characterized by a loss of consciousness and spasms. She was diagnosed with reactive hypoglycemia and treated with nutrition therapy, but the frequency and severity of the hypoglycemic episodes did not decrease. She was subsequently treated successfully with miglitol, an alpha-glucosidase inhibitor (α-GI) taken twice a day; other α-GIs (acarbose and voglibose) were not effective. In conclusion, the administration of miglitol was effective for preventing reactive hypoglycemia secondary to late dumping syndrome.
Related Concept Videos
Hypoglycemia and Glucagon
Hypoglycemia
Oral Hypoglycemic Agents: Glinides
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
